COMBRETASTATIN ANALOGS FOR USE IN THE TREATMENT OF CANCER
申请人:Schobert Rainer
公开号:US20130137740A1
公开(公告)日:2013-05-30
The present invention relates to specific analogs of combretastatin, in particular the compounds of formula (I) as described and defined herein, and pharmaceutical compositions comprising the compounds, as well as their medical use, in particular in the treatment or prevention of cancer, including multidrug-resistant cancer.
Combretastatin analogs for use in the treatment of cancer
申请人:Universität Bayreuth
公开号:EP2566851B1
公开(公告)日:2015-01-14
US8980933B2
申请人:——
公开号:US8980933B2
公开(公告)日:2015-03-17
[EN] COMBRETASTATIN ANALOGS FOR USE IN THE TREATMENT OF CANCER<br/>[FR] ANALOGUES DE LA COMBRÉTASTATINE POUR UTILISATION DANS LE TRAITEMENT DU CANCER
申请人:UNIV BAYREUTH
公开号:WO2011138409A1
公开(公告)日:2011-11-10
The present invention relates to specific analogs of combretastatin, in particular the compounds of formula (I) as described and defined herein, and pharmaceutical compositions comprising the compounds, as well as their medical use, in particular in the treatment or prevention of cancer, including multidrug-resistant cancer.